SCHEMBL7082402

SCHEMBL7082402

OCCc1ccc[c]c1C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17046318 0.85 PDK2 (0.33)
SCHEMBL27944348 0.81 ALDH1A1 (0.31)
SCHEMBL27584943 0.81 TDP1 (0.30) TDP1
SCHEMBL16951213 0.81 AR (0.33)
SCHEMBL11067601 0.79 LIPG (0.35)
SCHEMBL3464470 0.77 LIPG (0.41)
SCHEMBL27937767 0.77
SCHEMBL7401991 0.77 GABRA1 (0.40)
SCHEMBL27899133 0.77 PNMT (0.34)
SCHEMBL5311184 0.76 LIPG (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103347864-A For treating diseases caused by Lp-PLA2Pyrimidone compounds for mediated diseases or conditions GLAXO GROUP LTD 2013-10-09 CN disclosed
EP-1280784-A2 BIOLOGICALLY ACTIVE 4H-BENZO 1,4]OXAZIN-3-ONES Ortho-McNeil Pharmaceutical, Inc. (US) 2003-02-05 EP disclosed
WO-2001087862-A2 BIOLOGICALLY ACTIVE 4H-BENZO[1,4]OXAZIN-3-ONES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-22 WO disclosed